Dermatologic adverse events resulting from oncologic therapy are common and negatively
impact patients' quality of life. Dermatologic adverse events include toxicity of the skin, oral …

Background Checkpoint inhibitors have revolutionized advanced melanoma care; however,
their cutaneous side effects have not been definitively elucidated. Objective To identify the …

Background: Chemotherapy often results in dermatologic toxicities, which decrease quality
of life (QOL) of cancer patients. These adverse skin reactions sometimes happen …

When this article was published in the March 2022 issue, it was inadvertently assigned a
new DOI (DOI: 10.1097/01. ASW. 0000818572.31307. 7b) rather than receiving the same …

Colorectal cancer (CRC) is one of the most common cancers worldwide with a high
incidence and mortality. Although many treatment options are available in stage IV disease …

The past decades have witnessed a rapid increase in the use of molecularly targeted
therapies. One class of agents includes the epidermal growth factor receptor inhibitors …

Importance Assessment of type, severity, and impact of dermatologic adverse events (DAEs)
necessitates well-developed and validated clinician-reported outcome measures …

Introduction Skin has been used as an administration route for local or systemic action since
ancient times. The efficacy and toxicity of any product applied to the skin is determined by …

The combination of highly specific targeting ability and potent killing effect has made
antibody-drug conjugates (ADCs) a popular area of focus in the development of anti-cancer …

Purpose The purposes of this study were to assess the levels of symptom distress, body
image, and epidermal growth factor receptor inhibitors (EGFRI)-associated health-related …